According to reports six senior clinicians at the Faculty of Health Sciences at the University of the Witwatersrand in South Africa, have volunteered to participate in South Africa’s first Covid-19 vaccine trial.
Dean of the Faculty of Health Sciences at the University, Martin Veller said it is very appropriate that healthcare professionals and people who are involved in the research of the environment also get involved in the trial process.
The Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes COVID-19.
Martin Veller said “these are unprecedented times. Coronavirus is going to affect everybody in the world. We need a vaccine and the more people get involved in finding a suitable vaccine the better”.
According to a member of the Progressive Health Forum, Aslam Dasoo, there has been some concern, among the public but he assured that there is nothing to be afraid of.
“There is the benefit that if the vaccine works and if I get the vaccine shot – if it is not the placebo – I will be protected. There are a number of reasons, but mostly demonstrate that this is something that should be supported and encouraged and that no one is afraid of it” Dasoo noted.
Meanwhile, Professor of Vaccinology at the University of the Witwatersrand Shabir Madhi, said: “We have to wait for cases of Covid-19 to develop amongst the volunteers, and unfortunately, this is not because we are infecting people, but rather that is the nature of the virus that people are being exposed and becoming infected”.
However, South Africa is the only place the clinical trial of a Covid-19 vaccine is taking place and the African Union and the World Health Organization and some other agencies are hoping that the number of clinical trials will increase across the continent to help establish a sizable amount of data which will be used to certify the results of the Vaccine.
By Amos Ekow Coffie | talksafrica.com